Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT.

BACKGROUND Results of randomized clinical trials (RCTs) are needed to assess the efficacy of lung cancer screening with low-dose chest computed tomography (CT) in reducing lung cancer mortality. We report design and results of enrolment and baseline screening test in the ITALUNG trial, a RCT. METHODS Invitation letters were sent to subjects of 55-69 years of age clients of 269 general practitioners. Smokers or former smokers of at least 20 pack/years were eligible and after written consent were randomized in an active arm undergoing a low-dose CT annually for 4 years and in a control arm receiving no screening. Management of positive screening test was carried out using follow-up low-dose CT, fluorodeoxyglucose positron emission tomography, fine needle aspiration cytology and fiber optic bronchoscopy. RESULTS A sample of 3206 eligible subjects was achieved by sending 71,232 letters (enrolment efficacy = 4.5%). Subjects in control (n = 1593) and active (n = 1613) arm were balanced for age, gender and smoking history. Two-hundred and seven (12.8%) subjects did not undergo CT after randomization. The baseline screening test was positive in 426 (30.3%) of 1406 subjects. Twenty-one lung cancers (prevalence = 1.5%) were found in 20 subjects: 18 non-small cell lung cancer (NSCLC), 2 small cell lung cancer (SCLC) and a case of typical carcinoid. Ten NSCLC (47.6%) were in Stage I. Sixteen fine needle aspirations were performed in 15 lung cancers, with a positive result in 12 (75%) cases. One biopsy only (6.3%) was performed on a benign lesion. Seventeen lung cancers (81%) were treated with surgical resection in 16 subjects. One subject underwent surgery for a benign lesion (5.5% of all surgical resections). CONCLUSIONS Recruitment by mail of high risk subjects for a lung cancer screening RCT is feasible but not efficient. Results of the baseline screening test in the active arm of the ITALUNG trial are substantially in line with those of RCT and observational studies.

[1]  C. Begg,et al.  Computed tomography screening and lung cancer outcomes. , 2007, Revista portuguesa de pneumologia.

[2]  G. Bepler,et al.  Screening for lung cancer. , 2000, The New England journal of medicine.

[3]  E. Paci.  Observational, One-Arm Studies and Randomized Population-Based Trials for Evaluation of the Efficacy of Lung Cancer Screening , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[4]  A. Scarpa,et al.  Pathology and Genetics , 2010 .

[5]  C. Henschke.  Early lung cancer action project , 2000, Cancer.

[6]  Ugo Pastorino,et al.  Computed tomography screening and lung cancer outcomes. , 2007, JAMA.

[7]  E. Berg,et al.  World Health Organization Classification of Tumours , 2002 .

[8]  C. Comin,et al.  EU–USA pathology panel for uniform diagnosis in randomised controlled trials for HRCT screening in lung cancer , 2006, European Respiratory Journal.

[9]  R. V. van Klaveren,et al.  The Liverpool Statement 2005: priorities for the European Union/United States spiral computed tomography collaborative group. , 2006, Journal of Thoracic Oncology.

[10]  R. Grilli,et al.  Does provision of an evidence‐based information change public willingness to accept screening tests? , 2000, Health expectations : an international journal of public participation in health care and health policy.

[11]  M. Mascalchi,et al.  Screening of lung cancer with low dose spiral CT: results of a three year pilot study and design of the randomised controlled trial ''Italung-CT''. , 2005, La Radiologia medica.

[12]  F. Fazio,et al.  Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results , 2003, The Lancet.

[13]  Antoine Flahault,et al.  Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). , 2007, Lung cancer.

[14]  Peter B Bach,et al.  Screening for lung cancer: the guidelines. , 2003, Chest.

[15]  S. Swensen,et al.  Screening for lung cancer with low-dose spiral computed tomography. , 2000, American journal of respiratory and critical care medicine.

[16]  Federico Cappuzzo,et al.  Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial. , 2008, Lung cancer.

[17]  O. Miettinen,et al.  Screening for lung cancer : Lung Cancer , 2000 .

[18]  Paul Pinsky,et al.  Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute. , 2004, Chest.

[19]  O S Miettinen,et al.  Early Lung Cancer Action Project , 2001, Cancer.

[20]  J. Jett.  Limitations of Screening for Lung Cancer with Low-Dose Spiral Computed Tomography , 2005, Clinical Cancer Research.

[21]  J. Habbema,et al.  Risk‐based selection from the general population in a screening trial: Selection criteria, recruitment and power for the Dutch‐Belgian randomised lung cancer multi‐slice CT screening trial (NELSON) , 2007, International journal of cancer.

[22]  P. Magee,et al.  Effect of purified rat and hamster hepatic glutathione S-transferases on the microsome mediated binding of aflatoxin B1 to DNA. , 1986, Cancer letters.

[23]  S J Swensen,et al.  A Consensus Statement of the Society of Thoracic Radiology: Screening for Lung Cancer with Helical Computed Tomography , 2001, Journal of thoracic imaging.

[24]  W. Heindel,et al.  Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers. , 2002, Radiology.

[25]  Stefan Diederich,et al.  Screening for early lung cancer with low-dose spiral computed tomography , 2003, The Lancet.

[26]  O. Miettinen,et al.  Survival of Patients with Stage I Lung Cancer Detected on CT Screening , 2008 .